CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corporation

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Covista (CVSA) and Walmart (WMT) with bullish se...

Analysts’ Top Consumer Goods Picks: Covista (CVSA), Walmart (WMT)

An update from CVS Group plc ( ($GB:CVSG) ) is now available. CVS Group plc, the UK-listed veterinary services provider with operations in the UK a...

CVS Group Confirms Total Voting Rights at Just Over 70 Million Shares

An announcement from CVS Group plc ( ($GB:CVSG) ) is now available. CVS Group plc, a major veterinary services provider operating in the UK and Aus...

CVS Group updates total voting rights following share capital confirmation

CV Sciences ( ($CVSI) ) has provided an update. CV Sciences reported its fiscal 2025 and fourth-quarter 2025 results on March 26, 2026, showing rev...

CV Sciences Reports 2025 Results and Profitability Improvements

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LENZ Therapeutics (LENZ) and CVS Health (CVS) with b...

Analysts’ Top Healthcare Picks: LENZ Therapeutics (LENZ), CVS Health (CVS)

Barclays analyst maintained a Hold rating on CVS Group plc today and set a price target of £13.40. CVS Group plc has an analyst consensus of Modera...

Barclays Sticks to Their Hold Rating for CVS Group plc (CVSG)

An announcement from CVS Health ( ($CVS) ) is now available. On March 18, 2026, CVS Health’s board elected former Elevance Health chief financial o...

CVS Health Adds Veteran Finance Leader to Board

Novo Nordisk ($NVO) has secured U.S. FDA approval for Wegovy HD, a higher‑dose 7.2 mg version of its blockbuster weight‑loss drug. The new dose is ...

Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand

Analysts are intrested in these 5 stocks: ( ($CVS) ), ( ($NIO) ) and ( ($WM) ). Here is a breakdown of their recent ratings and the rationale behin...

CVS, Nio, WM: Trending Analyst Moves Investors Must See

CV Sciences ( ($CVSI) ) has provided an announcement. On March 4, 2026, CV Sciences, Inc. entered into an agreement with an institutional investor ...

CV Sciences Restructures Debt with New Convertible Note Deal

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health today and set a price target of $93.00. According to TipRanks, Mok CFA is an ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CVS	$73.49	0.00%	6.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CVS	$73.49	0%	6.03M
3
4
5
6

CVS

CVS

Get CVS Health Corporation Data in Excel

Get CVS Health Corporation Data in Excel